Sponsor or institution

Clinical trials and research at Juventas Cell Therapy Ltd.

• 9Clinical trials
• 1Country

Newest trials

All recruiting trials (9)

• HY001N cell injection for autoimmune hemolytic anemia after failing three or more treatments

  This trial tests whether HY001N cell injections are safe and can help adults with autoimmune hemolytic anemia who have not responded to at least three therapies.

  Recruiting Phase 1 Juventas Cell Therapy Ltd. · Tianjin · NCT07748533

• CNCT19 CAR‑T treatment for relapsed or refractory antibody-mediated neurological autoimmune diseases

  This trial will test whether a single CNCT19 CAR‑T cell injection is safe and can help adults (18–75) with relapsed or treatment‑resistant antibody‑mediated neurological autoimmune diseases.

  Recruiting Early Phase 1 Juventas Cell Therapy Ltd. · Beijing · NCT07275736

• Inaticabtagene autoleucel for refractory SLE-related immune thrombocytopenia

  This study will test a personalized CAR‑T cell treatment (inaticabtagene autoleucel) to try to raise platelet counts in adults with SLE-related immune thrombocytopenia that has not responded to standard therapies.

  Recruiting Phase 1 Juventas Cell Therapy Ltd. · Beijing, Beijing Municipality · NCT06826430

• Long-term follow-up for people treated with inaticabtagene autoleucel

  This program will follow people who received inaticabtagene autoleucel to see if annual monitoring finds delayed side effects up to 15 years after their infusion.

  Recruiting Juventas Cell Therapy Ltd. · Tianjin, Tianjin Municipality · NCT06461351

• Treatment with Inaticabtagene Autoleucel for Adult Leukemia Patients

  This study is testing a new treatment called Inaticabtagene Autoleucel to see if it helps adults with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia feel better and stay safe during their recovery.

  Recruiting at 10 sites Juventas Cell Therapy Ltd. · Beijing, Beijing Municipality and 9 other locations · NCT06450067

• Using CNCT19 cell therapy to treat difficult autoimmune diseases

  This study tests if a new cell therapy called CNCT19 can help people with tough autoimmune diseases like lupus feel better when other treatments haven't worked.

  Recruiting Early Phase 1 Juventas Cell Therapy Ltd. · Zhengzhou, Henan · NCT06316791

• Treatment of relapsed or refractory B-cell leukemia in children and adolescents

  This study is testing a new treatment called CNCT19 to see if it can help children and teenagers with relapsed or hard-to-treat B-cell leukemia feel better and live longer.

  Recruiting at 6 sites Phase 1/2 Juventas Cell Therapy Ltd. · Hefei, Anhui and 8 other locations · NCT05667506

• CNCT19 cell injection for treating relapsed or refractory acute lymphoblastic leukemia

  This study is testing a new cell injection called CNCT19 to see if it can help people with relapsed or hard-to-treat acute lymphoblastic leukemia feel better.

  Recruiting at 10 sites Phase 2 Juventas Cell Therapy Ltd. · Beijing, Beijing Municipality and 10 other locations · NCT04684147

• Treatment of relapsed or refractory Non-Hodgkin's Lymphoma with CNCT19 Cell Injection

  This study is testing if a single injection of CNCT19 cells can help people with relapsed or refractory Non-Hodgkin's Lymphoma feel better and improve their condition.

  Recruiting at 17 sites Phase 2 Juventas Cell Therapy Ltd. · Beijing, Beijing Municipality and 16 other locations · NCT04586478

Quick answers

How many clinical trials run by Juventas Cell Therapy Ltd. are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 2, Phase 2: 2, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →